News|Articles|October 31, 2024

WCG Meets Enrollment 24 Months Early for Top 5 Pharma’s Decentralized Trial

Author(s)WCG Clinical

A sponsor needed to get their Phase II dermatology study enrollment back on track. The study was underway for 11 months across 32 sites globally with only 20 subjects enrolled to date. With WCG support, enrollment was concluded 24 months ahead of schedule.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

Leveraging remote-based regional hubs in FSP partnerships
June 26th 2025
Establishing a Bespoke Outsourcing Arrangement with Hybrid FSP/FSO Partnerships
June 26th 2025
2025 FSP Trends Report
June 26th 2025
Focus on biotech: Harnessing FSP engagements to deliver on-time, on-budget
June 19th 2025
FSP Outsourcing in Clinical Research: Trends and Opportunities
June 9th 2025
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025

Trending on Applied Clinical Trials Online

Latest NIMBLE Study Results Highlight Progress in gMG Research

Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients

Q&A: Strategies for Successful Global Clinical Trial Delivery

Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients

© 2025 MJH Life Sciences^®

All rights reserved.